Cheyne-Stokes respiration (CSR) is characterized by a pattern of cyclic oscillations of tidal volume and respiratory rate with periods of hyperpnea alternating with hypopnea or apnea in patients with heart failure. CSR harms the failing heart through intermittent hypoxia brought about by apnea and hypopnea and recurrent sympathetic surges. CSR impairs the quality of life and increases cardiac mortality in patients with heart failure. Thus, CSR should actively be pursued in patients with severe heart failure. When CSR persists despite optimal therapy of heart failure, noninvasive adaptive servoventilation is currently the most promising treatment.

Keywords:
Cheyne-Stokes respiration, Central sleep apnea, Heart failure, Adaptive servo-ventilation
1.
Sharma B, Owens R, Malhotra A: Sleep in congestive heart failure. Med Clin North Am 2010;94:447–464.
2.
Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, Lopez JA, Ballester E, Guerra JM, Sopena JJ: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375–380.
3.
Ulrich S, Fischler M, Speich R, Bloch KE: Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 2008;133:1375–1380.
4.
Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD: Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 1996;154:376–381.
5.
Brack T, Thuer I, Clarenbach CF, Senn O, Noll G, Russi EW, Bloch KE: Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 2007;132:1463–1471.
6.
Cheyne J: A case of apoplexy in which the fleshy part of the heart is turned to fat. Dublin Hospi Rep 1818;2:216–223.
7.
Stokes W: The diseases of the heart and the aorta. Dublin Hospital Report, Hodges & Smith, 1854, pp 323–326.
8.
Brack T, Bloch KE: Central sleep apnoea; in Palange P, Simonds A (eds): ERS Handbook of Respiratory Medicine. Lausanne, European Respiratory Society, 2010, pp 410–413.
9.
Pepin JL, Chouri-Pontarollo N, Tamisier R, Levy P: Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy. Sleep Med Rev 2006;10:33–47.
10.
Cormican LJ, Williams A: Sleep disordered breathing and its treatment in congestive heart failure. Heart 2005;91:1265–1270.
11.
Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD: Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 2009;15:279–285.
12.
Javaheri S: Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006;106:21–28.
13.
Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA, Cowie MR, Morrell MJ, Simonds AK: A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007;9:243–250.
14.
MacDonald M, Fang J, Pittman SD, White DP, Malhotra A: The current prevalence of sleep disordered breathing in congestive heart failure patients treated with β-blockers. J Clin Sleep Med 2008;4:38–42.
15.
Ferrier K, Campbell A, Yee B, Richards M, O’Meeghan T, Weatherall M, Neill A: Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005;128:2116–2122.
16.
Mared L, Cline C, Erhardt L, Berg S, Midgren B: Cheyne-Stokes respiration in patients hospitalised for heart failure. Respir Res 2004;5:14–20.
17.
Schulz R, Blau A, Borgel J, Duchna HW, Fietze I, Koper I, Prenzel R, Schadlich S, Schmitt J, Tasci S, Andreas S: Sleep apnoea in heart failure. Eur Respir J 2007;29:1201–1205.
18.
Paulino A, Damy T, Margarit L, Stoica M, Deswarte G, Khouri L, Vermes E, Meizels A, Hittinger L, d’Ortho MP: Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis 2009;102:169–175.
19.
Roebuck T, Solin P, Kaye DM, Bergin P, Bailey M, Naughton MT: Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004;23:735–740.
20.
Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V: Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9:251–257.
21.
Luo Q, Zhang HL, Tao XC, Zhao ZH, Yang YJ, Liu ZH: Impact of untreated sleep apnea on prognosis of patients with congestive heart failure. Int J Cardiol 2010;144:420–422.
22.
Bradley TD, Floras JS: Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373:82–93.
23.
Schulz R, Baseler G, Ghofrani HA, Grimminger F, Olschewski H, Seeger W: Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 2002;19:658–663.
24.
Nopmaneejumruslers C, Kaneko Y, Hajek V, Zivanovic V, Bradley TD: Cheyne-Stokes respiration in stroke: relationship to hypocapnia and occult cardiac dysfunction. Am J Respir Crit Care Med 2005;171:1048–1052.
25.
Bonnin-Vilaplana M, Arboix A, Parra O, Garcia-Eroles L, Montserrat JM, Massons J: Sleep-related breathing disorders in acute lacunar stroke. J Neurol 2009;256:2036–2042.
26.
Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H, Roselle GA: Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995;122:487–492.
27.
Padeletti M, Green P, Mooney AM, Basner RC, Mancini DM: Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med 2009;10:353–360.
28.
Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999;99:1574–1579.
29.
Javaheri S: A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 1999;341:949–954.
30.
Walsh JT, Andrews R, Evans A, Cowley AJ: Failure of ‘effective’ treatment for heart failure to improve normal customary activity. Br Heart J 1995;74:373–376.
31.
Hastings PC, Vazir A, O’Driscoll DM, Morrell MJ, Simonds AK: Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 2006;27:748–755.
32.
Carmona-Bernal C, Ruiz-Garcia A, Villa-Gil M, Sanchez-Armengol A, Quintana-Gallego E, Ortega-Ruiz F, Baron-Esquivias G, Capote F: Quality of life in patients with congestive heart failure and central sleep apnea. Sleep Med 2008;9:646–651.
33.
Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ: A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003;168:1109–1114.
34.
Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT: Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 2003;123:1119–1126.
35.
Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sanchez-Armengol A, Martinez-Martinez A, Capote F: Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest 2005;127:1667–1673.
36.
Oldenburg O, Lamp B, Freivogel K, Bitter T, Langer C, Horstkotte D: Low night-to-night variability of sleep disordered breathing in patients with stable congestive heart failure. Clin Res Cardiol 2008;97:836–842.
37.
Leung RS, Diep TM, Bowman ME, Lorenzi-Filho G, Bradley TD: Provocation of ventricular ectopy by Cheyne-Stokes respiration in patients with heart failure. Sleep 2004;27:1337–1343.
38.
Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P: Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003;107:727–732.
39.
Leung RS, Floras JS, Lorenzi-Filho G, Rankin F, Picton P, Bradley TD: Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med 2003;167:1534–1539.
40.
Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ: Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645–1650.
41.
Hanly PJ, Zuberi-Khokhar NS: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996;153:272–276.
42.
Javaheri S, Caref EB, Chen E, Tong KB, Abraham WT: Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med 2011;183:539–546.
43.
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435–1440.
44.
Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD: Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000;102:61–66.
45.
Corra U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P: Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 2006;113:44–50.
46.
Javaheri S, Shukla R, Zeigler H, Wexler L: Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028–2034.
47.
Vazir A, Hastings PC, Papaioannou I, Poole-Wilson PA, Cowie MR, Morrell MJ, Simonds AK: Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure. Respir Med 2008;102:831–839.
48.
Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD: Overnight shift from obstructive to central apneas in patients with heart failure: role of PC O2 and circulatory delay. Circulation 2001;103:238–243.
49.
Mortara A, Sleight P, Pinna GD, Maestri R, Capomolla S, Febo O, La Rovere MT, Cobelli F: Association between hemodynamic impairment and Cheyne-Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999;84:900–904.
50.
Lorenzi-Filho G, Azevedo ER, Parker JD, Bradley TD: Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 2002;19:37–40.
51.
Kohnlein T, Welte T, Tan LB, Elliott MW: Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 2002;20:934–941.
52.
Chapman KR, Bruce EN, Gothe B, Cherniack NS: Possible mechanisms of periodic breathing during sleep. J Appl Physiol 1988;64:1000–1008.
53.
Khoo MC, Gottschalk A, Pack AI: Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol 1991;70:2014–2024.
54.
Davies RJ, Bennet LS, Barbour C, Tarassenko L, Stradling JR: Second by second patterns in cortical electroencephalograph and systolic blood pressure during Cheyne-Stokes. Eur Respir J 1999;14:940–945.
55.
Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA: Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 2002;165:1251–1260.
56.
Javaheri S: Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234–237.
57.
Arzt M, Harth M, Luchner A, Muders F, Holmer SR, Blumberg FC, Riegger GA, Pfeifer M: Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 2003;107:1998–2003.
58.
Mansfield D, Kaye DM, Brunner La RH, Solin P, Esler MD, Naughton MT: Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003;107:1396–1400.
59.
Vermes E, Fonkoua H, Kirsch M, Damy T, Margarit L, Hillion ML, Hittinger L, d’Ortho MP: Resolution of sleep-disordered breathing with a biventricular assist device and recurrence after heart transplantation. J Clin Sleep Med 2009;5:248–250.
60.
Alex CG, Onal E, Lopata M: Upper airway occlusion during sleep in patients with Cheyne-Stokes respiration. Am Rev Respir Dis 1986;133:42–45.
61.
Dark DS, Pingleton SK, Kerby GR, Crabb JE, Gollub SB, Glatter TR, Dunn MI: Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome. Improvement following medical therapy. Chest 1987;91:833–836.
62.
Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ: Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995;73:237–241.
63.
Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J: Relationship between β-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130–135.
64.
Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherison C, Tunon DL, Haissaguerre M, Clementy J: Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404–412.
65.
Luthje L, Unterberg-Buchwald C, Dajani D, Vollmann D, Hasenfuss G, Andreas S: Atrial overdrive pacing in patients with sleep apnea with implanted pacemaker. Am J Respir Crit Care Med 2005;172:118–122.
66.
Unterberg C, Luthje L, Szych J, Vollmann D, Hasenfuss G, Andreas S: Atrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome. Eur Heart J 2005;26:2568–2575.
67.
Melzer C, Fietze I, Duru F, Glos M, Lemola K, Bloch KE, Erickson M, Cho Y, Markowitz T, Theres H: Nocturnal overdrive pacing for the treatment of sleep apnea syndrome. Sleep 2006;29:1197–1202.
68.
Kara T, Novak M, Nykodym J, Bybee KA, Meluzin J, Orban M, Novakova Z, Lipoldova J, Hayes DL, Soucek M, Vitovec J, Somers VK: Short-term effects of cardiac resynchronization therapy on sleep-disordered breathing in patients with systolic heart failure. Chest 2008;134:87–93.
69.
Hagenah G, Zapf A, Schuttert JB: Cheyne-Stokes respiration and prognosis in modern-treated congestive heart failure. Lung 2010;188:309–313.
70.
Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006;173:1300–1308.
71.
Bittar G, Friedman HS: The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991;99:1415–1420.
72.
Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562–567.
73.
Andreas S, Reiter H, Luthje L, Delekat A, Grunewald RW, Hasenfuss G, Somers VK: Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure. Circulation 2004;110:2157–2162.
74.
Younes M: Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med 2004;169:623–633.
75.
Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH: Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989;96:480–488.
76.
Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H: Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996;27:1486–1490.
77.
Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ: Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998;19:922–928.
78.
Krachman SL, D’Alonzo GE, Berger TJ, Eisen HJ: Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999;116:1550–1557.
79.
Gold AR, Bleecker ER, Smith PL: A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am Rev Respir Dis 1985;132:220–223.
80.
Andreas S, Hagenah G, Moller C, Werner GS, Kreuzer H: Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 1996;78:1260–1264.
81.
Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H: Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 2006;70:1–7.
82.
Toyama T, Seki R, Kasama S, Isobe N, Sakurai S, Adachi H, Hoshizaki H, Oshima S, Taniguchi K: Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J 2009;73:299–304.
83.
Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD: Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173–3180.
84.
Teschler H, Dohring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001;164:614–619.
85.
Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA: Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 2002;165:1245–1250.
86.
Andreas S, Weidel K, Hagenah G, Heindl S: Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 1998;12:414–419.
87.
Lorenzi-Filho G, Rankin F, Bies I, Douglas BT: Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999;159:1490–1498.
88.
Khayat RN, Xie A, Patel AK, Kaminski A, Skatrud JB: Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 2003;123:1551–1560.
89.
Thomas RJ, Daly RW, Weiss JW: Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. Sleep 2005;28:69–77.
90.
Szollosi I, Jones M, Morrell MJ, Helfet K, Coats AJ, Simonds AK: Effect of CO2 inhalation on central sleep apnea and arousals from sleep. Respiration 2004;71:493–498.
91.
Mebrate Y, Willson K, Manisty CH, Baruah R, Mayet J, Hughes AD, Parker KH, Francis DP: Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes. J Appl Physiol 2009;107:696–706.
92.
Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995;152:473–479.
93.
Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD: Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995;151:92–97.
94.
Kaye DM, Mansfield D, Aggarwal A, Naughton MT, Esler MD: Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001;103:2336–2338.
95.
Mehta S, Liu PP, Fitzgerald FS, Allidina YK, Douglas BT: Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy. Am J Respir Crit Care Med 2000;161:128–134.
96.
Steiner S, Schannwell CM, Strauer BE: Left ventricular response to continuous positive airway pressure: role of left ventricular geometry. Respiration 2008;76:393–397.
97.
Philip-Joet FF, Paganelli FF, Dutau HL, Saadjian AY: Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure. Respiration 1999;66:136–143.
98.
Brack T, Jubran A, Laghi F, Tobin MJ: Fluctuations in end-expiratory lung volume during Cheyne-Stokes respiration. Am J Respir Crit Care Med 2005;171:1408–1413.
99.
Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS: Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025–2033.
100.
Bradley TD, Phillipson EA: Central sleep apnea. Clin Chest Med 1992;13:493–505.
101.
Kiely JL, Deegan P, Buckley A, Shiels P, Maurer B, McNicholas WT: Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax 1998;53:957–962.
102.
Randerath WJ: Treatment options in Cheyne-Stokes respiration. Ther Adv Respir Dis 2010;4:341–351.
103.
Willson GN, Wilcox I, Piper AJ, Flynn WE, Norman M, Grunstein RR, Sullivan CE: Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur Respir J 2001;17:1250–1257.
104.
Dohi T, Kasai T, Narui K, Ishiwata S, Ohno M, Yamaguchi T, Momomura S: Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 2008;72:1100–1105.
105.
Johnson KG, Johnson DC: Bilevel positive airway pressure worsens central apneas during sleep. Chest 2005;128:2141–2150.
106.
Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Rouault S, d’Ortho MP: Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006;92:337–342.
107.
Morgenthaler TI, Gay PC, Gordon N, Brown LK: Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 2007;30:468–475.
108.
Oldenburg O, Schmidt A, Lamp B, Bitter T, Muntean BG, Langer C, Horstkotte D: Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail 2008;10:581–586.
109.
Hastings PC, Vazir A, Meadows GE, Dayer M, Poole-Wilson PA, McIntyre HF, Morrell MJ, Cowie MR, Simonds AK: Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol 2010;139:17–24.
110.
Arzt M, Wensel R, Montalvan S, Schichtl T, Schroll S, Budweiser S, Blumberg FC, Riegger GA, Pfeifer M: Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 2008;134:61–66.
111.
Randerath WJ, Galetke W, Kenter M, Richter K, Schafer T: Combined adaptive servo-ventilation and automatic positive airway pressure (anticyclic modulated ventilation) in co-existing obstructive and central sleep apnea syndrome and periodic breathing. Sleep Med 2009;10:898–903.
112.
Randerath WJ, Galetke W, Stieglitz S, Laumanns C, Schafer T: Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration. Sleep Med 2008;9:823–830.
113.
Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, Yamaguchi T, Yamashina A, Momomura SI: Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 2010;3:140–148.
114.
Pusalavidyasagar SS, Olson EJ, Gay PC, Morgenthaler TI: Treatment of complex sleep apnea syndrome: a retrospective comparative review. Sleep Med 2006;7:474–479.
115.
Randerath WJ, Anduleit N, Treml M, et al: Long-term efficacy of adaptive servo-ventilation in patients with co-existing obstructive sleep apnoea (OSA) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controled trial (abstract). Eur Respir J 2009;34:38s.
116.
Mehra R, Stone KL, Blackwell T, Ancoli-Israel S, Dam TT, Stefanick ML, Redline S: Prevalence and correlates of sleep-disordered breathing in older men: osteoporotic fractures in men sleep study. J Am Geriatr Soc 2007;131:109–117.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.